GANX icon

Gain Therapeutics
GANX

Overview Fund Trends Analyst Outlook Journalist POV

12 hedge funds and large institutions have $15M invested in Gain Therapeutics in 2021 Q1 according to their latest regulatory filings, with 12 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

Holders
12
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$8.15M
2
+$3.36M
3
+$982K
4
PCM
Prelude Capital Management
New York
+$867K
5
MS
Maven Securities
Jersey
+$340K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$8.15M
2
$3.36M
3
$982K
4
$867K
5
$340K
6
$339K
7
$232K
8
$222K
9
$214K
10
$209K
11
$91K
12
$12K